Suppr超能文献

有晶体眼后房型人工晶状体植入联合准分子原位角膜磨镶术矫正高度近视

Angle-supported phakic intraocular lenses followed by laser-assisted in situ keratomileusis for the correction of high myopia.

作者信息

Muñoz Gonzalo, Alió Jorge L, Montés-Micó Robert, Belda José I

机构信息

Refractive Surgery Department, Instituto Oftalmológico de Alicante, and the Division of Ophthalmology, Miguel Hernández University, Alicante, Spain.

出版信息

Am J Ophthalmol. 2003 Sep;136(3):490-9. doi: 10.1016/s0002-9394(03)00240-x.

Abstract

To evaluate the safety, effectiveness, predictability, and stability of the combination of angle-supported phakic intraocular lens (PIOL) implantation and laser-assisted in situ keratomileusis (LASIK) for the correction of high myopia. Noncomparative interventional case series. At the Instituto Oftalmológico de Alicante, Spain, 24 consecutive eyes of 12 patients with a preoperative spherical equivalent between -9 and -26 diopters were studied. Implantation of an angle-supported PIOL was done as the first surgery. Laser-assisted in situ keratomileusis was performed at least 6 months after PIOL surgery, once stability of topography and refraction were proved. Main outcome measures were uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), refraction, applanation tonometry, and corneal endothelial study (cell density, hexagonality, and coefficient of variation), with a minimum follow-up of 12 months after LASIK. The mean spherical equivalent refraction decreased from -15.17 +/- 5.15 diopters before PIOL implantation to -1.33 +/- 1.18 diopters after PIOL surgery and to 0.01 +/- 0.53 12 months after LASIK. Uncorrected visual acuity was 0.39 +/- 0.12 after PIOL surgery, increasing to 0.65 +/- 0.23 12 months after LASIK. There was an increase in 20/40 or better UCVA from 16.6% after PIOL surgery alone to 83.3% after addition of LASIK. At final follow-up, spherical equivalent was within +/- 1 diopter of emmetropia in 22 eyes (91.7%) and in 18 eyes (75%) within +/- 0.50 diopters. Vector analysis demonstrated that astigmatic components of refractive error after PIOL surgery were well corrected by LASIK. At final follow-up the mean endothelial cell loss was 4.88% (P <.001). There were no statistically significant differences between mean endothelial cell count, percentage of hexagonality, or coefficient of variation before LASIK and 12 months after LASIK, suggesting that no corneal endothelial damage was produced by LASIK itself. No sight-threatening complications occurred through the follow-up period. The combination of angle-supported PIOL implantation and LASIK appears to be a safe, effective, predictable, and stable procedure for the correction of high myopia. This paper emphasizes the benefits of adding LASIK to the use of PIOL alone.

摘要

评估有晶体眼后房型人工晶体(PIOL)植入联合准分子原位角膜磨镶术(LASIK)矫正高度近视的安全性、有效性、可预测性及稳定性。非对照性干预病例系列研究。在西班牙阿利坎特眼科研究所,对12例患者的24只眼进行了研究,术前等效球镜度数在-9至-26屈光度之间。首先进行有晶体眼后房型人工晶体植入手术。在PIOL手术后至少6个月,待地形图和屈光状态稳定后,再行准分子原位角膜磨镶术。主要观察指标包括裸眼视力(UCVA)、最佳矫正视力(BCVA)、屈光度数、压平眼压及角膜内皮研究(细胞密度、六角形细胞比例及变异系数),LASIK术后至少随访12个月。PIOL植入术前等效球镜平均屈光度数为-15.17±5.15屈光度,PIOL手术后降至-1.33±1.18屈光度,LASIK术后12个月为0.01±0.53屈光度。PIOL手术后裸眼视力为0.39±0.12,LASIK术后12个月增至0.65±0.23。仅行PIOL手术时,20/40或更好的裸眼视力者占16.6%,联合LASIK后增至83.3%。末次随访时,22只眼(91.7%)等效球镜度数在正视眼±1屈光度范围内,18只眼(75%)在±0.50屈光度范围内。矢量分析表明,PIOL手术后屈光不正的散光成分经LASIK得到良好矫正。末次随访时平均内皮细胞丢失率为4.88%(P<.001)。LASIK术前与术后12个月的平均内皮细胞计数、六角形细胞比例或变异系数之间无统计学显著差异,提示LASIK本身未造成角膜内皮损伤。随访期间未发生威胁视力的并发症。有晶体眼后房型人工晶体植入联合LASIK矫正高度近视似乎是一种安全、有效、可预测且稳定的手术方法。本文强调了在单纯使用PIOL基础上加用LASIK的益处。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验